马红霞

Ma Hongxia

  

1. Personal Information

Title/Position: Associate professor

Correspondence Address: Department of Social Medicine and

Health Education, Nanjing Medical University, 101 Longmian Av.,

Jiangning District, Nanjing, Jiangsu Province, 211166, P.R. China.

Telephone: (86)-25-86868437

Fax: (86)-25-86868437

E-mail: mahongxia@126.com

  

2. Education

INSTITUTION

DEGREE

(if applicable)

MM/YY

FIELD OF STUDY

Nanjing Medical University

B.Med.

07/03

Clinical Medicine

Nanjing Medical University

M.S.

07/06

Epidemiology

Nanjing Medical University

Ph.D

07/12

Epidemiology

UT MD Anderson Cancer Center, Texas, USA

Visiting Scientist

03/10

Epidemiology

 

3. Research Interests

Cancer molecular epidemiology: a) investigate biomarkers for prevention, diagnosis and prognosis of human cancer; b) clarify the biological mechanism of biomarkers in the development of cancer

  

4. Selected Publications

Xie K, Liang C, Li Q, Yan C, Wang C, Gu Y, Zhu M, Du F, Wang H, Dai J, Liu X, Jin G, Shen H, Ma H#, Hu Z#. Role of ATG10 expression quantitative trait loci in non-small cell lung cancer survival. Int J Cancer. 2016 Oct 1;139(7):1564-73.

Xie K*, Ma H*, Liang C, Wang C, Qin N, Shen W, Gu Y, Yan C, Zhang K, Dai N, Zhu M, Wu S, Wang H, Dai J, Jin G, Shen H, Hu Z.A functional variant in miR-155 regulation region contributes to lung cancer risk and survival.Oncotarget.2015 Dec 15;6(40):42781-92

Cao S, Wang S, Ma H#, Tang S, Sun C, Dai J, Wang C, Shu Y, Xu L, Yin R, Song X, Chen H, Han B, Li Q, Wu J, Bai C, Chen J, Jin G, Hu Z, Lu D#, Shen H#. Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy.Pharmacogenomics J. 2015 Mar 31. doi: 10.1038/tpj.2015.22. [Epub ahead of print]

Jin G*, Ma H*, Wu C, Dai J, Zhang R, Shi Y, Lu J, Miao X, Wang M, Zhou Y, Chen J, Li H, Pan S, Chu M, Lu F, Yu D, Jiang Y, Dong J, Hu L, Chen Y, Xu L, Shu Y, Pan S, Tan W, Zhou B, Lu D, Wu T, Zhang Z, Chen F, Wang X, Hu Z, Lin D, Shen H.Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in han chinese. Am J Hum Genet. 2012, 91(5):928-34. (*co-first author)

Ma H, Yuan H, Yuan Z, Yu C, Wang R, Jiang Y, Hu Z, Shen H, Chen N. Genetic Variations in Key MicroRNA Processing Genes and Risk of Head and Neck Cancer: A Case-Control Study in Chinese Population. PLoS One. 2012, 7(10):e47544.

Ma H, Zhou Z, Wei S, Liu Z, Pooley KA, Dunning AM, Svenson U, Roos G, Hosgood HD 3rd, Shen M, Wei Q. Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS One. 2011, 6(6):e20466.

Ma H, Yu H, Liu Z, Wang LE, Sturgis EM, Wei Q. Polymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neck. Pharmacogenet Genomics. 2012, 22(1):50-7.

Ma H, Chen J, Pan S, Dai J, Jin G, Hu Z, Shen H, Shu Y. Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population. Lung Cancer. 2011, 73(1):32-7.

Ma H, Shu Y, Pan S, Chen J, Dai J, Jin G, Hu Z, Shen H. Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese. Lung Cancer. 2011, 74(2):164-9.

Ma H, Hu Z, Wang H, Jin G, Wang Y, Sun W, Chen D, Tian T, Jin L, Wei Q, Lu D, Huang W, Shen H.ERCC6/CSB gene polymorphisms and lung cancer risk. Cancer Lett. 2009, 273(1):172-6.

 

5. Scholarly and Professional Activities

Member, American Association for Cancer Research (AACR)

Member, Epidemiology Branch of Jiangsu Prevention Medicine Association